Skin fragility and blistering with imatinib mesylate.
Verma
S M
SM
Murphy
G
G
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D001768:Blister / Q000139:chemically induced*; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*; D012867:Skin / Q000187:drug effects
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate